|
CDC26 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.298500E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.410600E-04 |
| Normal-vs-Stage2 |
1.537380E-03 |
| Normal-vs-Stage3 |
5.513500E-02 |
| Normal-vs-Stage4 |
1.888780E-01 |
| Stage1-vs-Stage2 |
7.008800E-01 |
| Stage1-vs-Stage3 |
2.826800E-01 |
| Stage1-vs-Stage4 |
4.165400E-01 |
| Stage2-vs-Stage3 |
2.079600E-01 |
| Stage2-vs-Stage4 |
2.620800E-01 |
| Stage3-vs-Stage4 |
9.128800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.080260E-02 |
| Normal-vs-AfricanAmerican |
5.57569999999341E-05 |
| Normal-vs-Asian |
5.811900E-02 |
| Caucasian-vs-AfricanAmerican |
8.030100E-02 |
| Caucasian-vs-Asian |
5.017600E-01 |
| AfricanAmerican-vs-Asian |
7.698000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.122950E-03 |
| Normal-vs-Female |
4.190300E-02 |
| Male-vs-Female |
8.913800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.783350E-03 |
| Normal-vs-Extreme_Weight |
5.778300E-03 |
| Normal-vs-Obese |
1.514200E-02 |
| Normal-vs-Extreme_Obese |
5.660900E-03 |
| Normal_Weight-vs-Extreme_Weight |
4.979800E-01 |
| Normal_Weight-vs-Obese |
3.599600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.675200E-01 |
| Extreme_Weight-vs-Obese |
7.550600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.688000E-01 |
| Obese-vs-Extreme_Obese |
2.142400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.203170E-01 |
| Normal-vs-Age(41-60Yrs) |
4.156700E-03 |
| Normal-vs-Age(61-80Yrs) |
2.744400E-03 |
| Normal-vs-Age(81-100Yrs) |
1.121170E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.110400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.880000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.277400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.333800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.653600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.920200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.134180E-02 |
| Normal-VS-Type2 PRCC |
4.811500E-04 |
| Normal-VS-KIRP CIMP |
6.888200E-01 |
| Normal-VS-Unclassified PRCC |
1.081380E-03 |
| Type1 PRCC-VS-Type2 PRCC |
8.874000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.456800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.723410E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.374400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.622600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.838100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.598900E-04 |
| Normal-vs-N1 |
2.432200E-01 |
| Normal-vs-N2 |
3.962200E-01 |
| N0-vs-N1 |
2.319800E-02 |
| N0-vs-N2 |
4.320000E-01 |
| N1-vs-N2 |
7.706800E-01 |
|
|
